SEC
Filing

SEC Filing Details

Document Details

Form
Filing Date
Feb 25, 2021
Document Date
Feb 25, 2021
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe